Belgium· BE-AMP-SAM042357-00
Phospholine Iodide 0,06 %
A medicinal product containing ecothiopate iodide, registered in Belgium by Efeka.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ecothiopate Iodide
- Manufacturer
- Efeka
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ecothiopate iodide in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/573006f7-d56c-4c20-b559-15ef9140d8a2 GET /v1/drugs/573006f7-d56c-4c20-b559-15ef9140d8a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, powder and solvent for solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Phospholine Iodide 0,06 %",
"name_fr": "Phospholine Iodide 0,06 %",
"name_nl": "Phospholine Iodide 0,06 %",
"amp_code": "SAM042357-00",
"strengths": [
"60.0000"
],
"pack_count": 1,
"substances": [
"Ecothiopate Iodide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": null,
"authorisation_numbers": [
"0188S 0003F013"
]
}See everything about ecothiopate iodide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.